高级搜索
以榄香烯乳为耐药调变剂联合化疗耐药胃癌临床观察[J]. 肿瘤防治研究, 1999, 26(3): 215-216.
引用本文: 以榄香烯乳为耐药调变剂联合化疗耐药胃癌临床观察[J]. 肿瘤防治研究, 1999, 26(3): 215-216.
Clinical Observations of Gastric Cancer Patients Treated with Chemotherapy and Elemene as a MDR Mediator[J]. Cancer Research on Prevention and Treatment, 1999, 26(3): 215-216.
Citation: Clinical Observations of Gastric Cancer Patients Treated with Chemotherapy and Elemene as a MDR Mediator[J]. Cancer Research on Prevention and Treatment, 1999, 26(3): 215-216.

以榄香烯乳为耐药调变剂联合化疗耐药胃癌临床观察

Clinical Observations of Gastric Cancer Patients Treated with Chemotherapy and Elemene as a MDR Mediator

  • 摘要: 目的:观察榄香烯乳有无逆转晚期胃癌患者对化疗药物的耐药性。方法:共选择42例晚期胃癌患者,随机分为三组:1单纯化疗组;2单纯榄香烯乳治疗组;3榄香烯乳联合化疗组。结果:单纯榄香烯乳治疗组有效率为9%,单纯化疗组为0%,榄香烯乳联合化疗组为28.6%。结论:榄香烯乳联合化疗可提高肿瘤细胞对化疗药物的敏感性,逆转晚期胃癌患者对化疗药物的耐药性。

     

    Abstract: To judge whether there was any effect of elemene in reversing the MDR in patients with advanced gastric cancer.

     

/

返回文章
返回